Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, …
Over the last 12 months, insiders at Hims & Hers Health, Inc. have bought $1.95M and sold $121.57M worth of Hims & Hers Health, Inc. stock.
On average, over the past 5 years, insiders at Hims & Hers Health, Inc. have bought $2.21M and sold $61.85M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Payne Christopher D (director) — $3.9M.
The last purchase of 110,000 shares for transaction amount of $1.95M was made by Payne Christopher D (director) on 2024‑05‑21.
2024-10-29 | Sale | Chief Legal Officer | 2,339 0.0012% | $23.16 | $54,171 | -11.42% | ||
2024-10-25 | Sale | Chief Commercial Officer | 17,304 0.0078% | $22.00 | $380,688 | 0.00% | ||
2024-10-21 | Sale | Chief Commercial Officer | 7,500 0.0035% | $22.20 | $166,500 | -11.67% | ||
2024-10-16 | Sale | PAO | 471 0.0003% | $22.64 | $10,663 | -5.37% | ||
2024-10-15 | Sale | Chief Commercial Officer | 75,493 0.0451% | $22.00 | $1.66M | -5.44% | ||
2024-10-15 | Sale | Chief Legal Officer | 2,339 0.0013% | $20.41 | $47,739 | -5.44% | ||
2024-10-14 | Sale | Chief Financial Officer | 269,739 0.1487% | $20.31 | $5.48M | +6.61% | ||
2024-10-07 | Sale | Chief Operating Officer | 58,750 0.0312% | $19.57 | $1.15M | +5.45% | ||
2024-10-07 | Sale | Chief Financial Officer | 9,868 0.0053% | $19.96 | $196,992 | +5.45% | ||
2024-10-02 | Sale | Chief Financial Officer | 11,581 0.0059% | $18.92 | $219,084 | +5.01% | ||
2024-10-01 | Sale | Chief Legal Officer | 2,339 0.0012% | $18.50 | $43,272 | +0.67% | ||
2024-10-01 | Sale | Chief Executive Officer | 333,332 0.1646% | $18.19 | $6.06M | +0.67% | ||
2024-09-20 | Sale | Chief Financial Officer | 12,651 0.0063% | $16.79 | $212,356 | +16.81% | ||
2024-09-20 | Sale | Chief Executive Officer | 45,767 0.022% | $16.33 | $747,434 | +16.81% | ||
2024-09-17 | Sale | Chief Commercial Officer | 25,550 0.0126% | $16.50 | $421,575 | +17.33% | ||
2024-09-17 | Sale | Chief Legal Officer | 2,339 0.0012% | $16.50 | $38,594 | +17.33% | ||
2024-09-17 | Sale | PAO | 10,017 0.0049% | $16.50 | $165,281 | +17.33% | ||
2024-09-16 | Sale | PAO | 472 0.0002% | $16.45 | $7,764 | +15.66% | ||
2024-09-05 | Sale | Chief Operating Officer | 11,749 0.0056% | $14.40 | $169,159 | +29.52% | ||
2024-09-04 | Sale | Chief Operating Officer | 11,749 0.0056% | $14.65 | $172,103 | +27.00% |
WELLS DAVID B | director | 146195 0.0703% | $23.08 | 4 | 3 | <0.0001% |
Okupe Oluyemi | Chief Financial Officer | 145763 0.0701% | $23.08 | 1 | 18 | +79.72% |
Payne Christopher D | director | 110000 0.0529% | $23.08 | 1 | 0 | |
Dudum Andrew | Chief Executive Officer | 67015 0.0322% | $23.08 | 2 | 34 | <0.0001% |
Maltz Jules A. | 10 percent owner | 0 0% | $23.08 | 2 | 3 | +68.81% |
The Vanguard Group | $221.38M | 6.66 | 14.31M | +0.97% | +$2.12M | <0.01 | |
BlackRock | $168.01M | 5.06 | 10.86M | +<0.01% | +$17,156.23 | <0.01 | |
Marshall Wace | $87.25M | 2.63 | 5.64M | +7.04% | +$5.74M | 0.09 | |
Institutional Venture Management Xvi Llc | $80.79M | 2.43 | 5.22M | -32.37% | -$38.68M | 93.86 | |
Institutional Venture Management Xv Llc | $80.79M | 2.43 | 5.22M | -32.37% | -$38.67M | 41.61 |